Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | March 26, 2010 |
| Target | Cortex Pharmaceuticals - AMPAKINE Compounds |
| Sector | Life Science |
| Buyer(s) | Biovail |
| Sellers(s) | RespireRx |
| Deal Type | Divestiture |
| Deal Value | 10M USD |
FILTER BY
Biovail Corp. is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets.
| Deal Context for Buyer | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science | 3 of 3 |
| Type: Divestiture | 2 of 2 |
| State: California | 1 of 1 |
| Country: United States | 3 of 3 |
| Year: 2010 | 1 of 1 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-05-06 |
GlaxoSmithKline - Wellbutrin XL
United States GlaxoSmithKline plc - Wellbutrin XL which is indicated for the treatment of major depressive disorder and seasonal affective disorder, was developed and is manufactured by Biovail and has been distributed by GSK in the United States since September 2003. |
Buy | $510M |
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Life Science |
| Employees | 2 |
| Revenue | 2M USD (2022) |
RespireRx is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders. RespireRx was founded in 1987 and is based in Glen Rock, New Jersey.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: California | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2010 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
